Newsfile Corp
15 Jun 2026, 18:38 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GeneDx lowered its full-year revenue guidance to $475-$490 million from the previous $540-$550 million. — A significant reduction in revenue guidance typically leads to immediate downward revisions of valuation and stock price.
-0.80GeneDx reported a $31.2 million impairment loss related to its acquisition of Fabric Genomics. — Impairments signal that a prior strategic acquisition failed to deliver expected value and negatively impact the balance sheet.
-0.60GeneDx's adjusted gross margin dropped from 74% to 69% in the first quarter of fiscal year 2026. — Compressing margins suggest deteriorating operational efficiency or pricing pressure.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
A securities class action lawsuit has been filed against GeneDx alleging the company failed to disclose material information. — Legal challenges and fraud allegations create uncertainty and potential future liability for the company.
Which stocks this story touches
The company is facing a securities class action lawsuit following a 49.2% stock price drop, missed revenue estimates, and a $31.2 million impairment loss.
The company is mentioned as being subject to a class action lawsuit application deadline.
The company is mentioned as being subject to a class action lawsuit application deadline.
TMX Group is mentioned as the provider of the news service and explicitly states it does not endorse the companies listed.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
